Role of a NSAID in the apparent cure of a fungal mycetoma

Ahmed, 1998, Unexpected high prevalence of secondary bacterial infection in patients with mycetoma, J Clin Microbiol, 36, 850, 10.1128/JCM.36.3.850-851.1998 Ahmed, 2004, Mycetoma caused by Madurella mycetomatis: a neglected infectious burden, Lancet Infect Dis, 4, 566, 10.1016/S1473-3099(04)01131-4 Ahmed, 2015, In vitro antifungal susceptibility of coelomycete agents of black grain eumycetoma to eight antifungals, Med Mycol., 53, 295, 10.1093/mmy/myu098 Caillot, 2010, Computer tomography in pulmonary invasive aspergillosis in hematological patients with neutropenia: a useful tool for diagnosis and assessment of outcome in clinical trials, Europ Journ Radiol, 74, e172, 10.1016/j.ejrad.2009.05.058 De Hoog, 2013, Phylogenic findings suggest possible new habitat and routes of infection of human eumycetoma, PLoS Negl Trop Dis, 7, e2229, 10.1371/journal.pntd.0002229 Develoux, 2016, Les mycétomes et leur traitement, J Med Mycol, 10.1016/j.mycmed.2016.03.005 Diallo, 2015, Mycétome actinomycosique extra-podal plurifocal : bonne réponse au traitement par l’association cotrimoxazole et AINS, J Mycol Med, 25, 297, 10.1016/j.mycmed.2015.09.006 Dupont, 2007, Hepatosplenic candidiasis: a new immune reconstitution inflammatory syndrome?, J Mycol Med, 17, 155, 10.1016/j.mycmed.2007.07.002 Fahal, 2004, Mycetoma: a thorn in the flesh, Trans R Soc Trop Med Hyg, 98, 3, 10.1016/S0035-9203(03)00009-9 Fahal, 1995, The host tissue reaction to Madurella mycetomatis: new classification, J Med Vet Mycol, 33, 15, 10.1080/02681219580000041 Fahal, 2011, The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis, Trans R Soc Trop Med Hyg, 105, 127, 10.1016/j.trstmh.2010.11.008 Kestens, 2008, Immunopathogenesis of immune reconstitution disease in HIV patients responding to antiretroviral therapy, Curr Opin HIV AIDS, 3, 419, 10.1097/COH.0b013e328302ebbb Kloezen, 2012, In vitro antifungal activity of isavuconazole against Madurella mycetomatis, Antimicrob Agents Chemother, 56, 6054, 10.1128/AAC.01170-12 Lacroix, 2005, Madurella mycetomatis mycetoma treated successfully with oral voriconazole, Br J Dermatol, 152, 1068, 10.1111/j.1365-2133.2005.06534.x Legrand, 2008, Adjuvant corticosteroid therapy for chronic disseminated candidiasis, Clin Infect Dis, 46, 696, 10.1086/527390 Loulergue, 2006, Successful treatment of black-grain mycetoma with voriconazole, Am J Trop Med Hyg, 75, 1106, 10.4269/ajtmh.2006.75.1106 Lynch, 1964, Mycetoma in the Sudan, Ann R Coll Surg, 35, 319 Mahgoub, 1984, Ketoconazole in the treatment of eumycetoma due to Madurella mycetomatis, Trans R Soc Trop Med Hyg, 78, 376, 10.1016/0035-9203(84)90126-3 Mhmoud, 2014, The combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infection, PloS Negl Trop Dis, 8, e2959, 10.1371/journal.pntd.0002959 Mattioni, 2013, Management of mycetomas in France, Med Mal Infect, 43, 286, 10.1016/j.medmal.2013.06.004 Mohamed, 2015, Mycetoma: epidemiology, treatment challenges and progress, Res Rep Trop Med, 6, 31 Müller, 2010, Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis, Lancet Infect Dis, 4, 251, 10.1016/S1473-3099(10)70026-8 Negroni, 2005, Posaconazole treatment of refractory eumycetoma and chromoblastomycosis, Rev Inst Med Trop Soa Paulo, 47, 339, 10.1590/S0036-46652005000600006 Netea, 2005, From the Th1/Th2 paradigm towards a Toll-like receptor/T-helper bias, Antimicrob Agents Chemother, 49, 3991, 10.1128/AAC.49.10.3991-3996.2005 Paugam, 1997, Clinical cure of fungal madura foot with oral itraconazole, Cutis, 60, 191 Peck, 2010, Precarious balance: Th17 cells in host defense, Infect Immun, 78, 32, 10.1128/IAI.00929-09 Rey, 1962, Données actuelles sur les mycétomes. À propos de 214 cas africains, Ann Derm Syph, 89, 511 Romani, 2008, Cell mediated immunity to fungi: a reassessment, Med Mycol, 46, 515, 10.1080/13693780801971450 Romani, 2011, Immunity to fungal infections, Nat Rev Imm, 11, 275, 10.1038/nri2939 Segretain, 1968, Recherches sur la présence d’agents de mycétomes dans le sol et sur les épineux du Sénégal et de la Mauritanie, Bull Soc Pathol Exot, 61, 194 van de Sande, 2013, Global burden of human mycetoma: a systematic review and meta-analysis, PLoS Negl Trop Dis, 7, e2550, 10.1371/journal.pntd.0002550 van Belkum Alex, 2011, In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafine, Antimicrob Agents Chemother, 55, 1771, 10.1128/AAC.01045-10 van de Veerdonk, 2010, T-cell subsets and antifungal host defenses, Curr Fungal Infect Rep, 4, 238, 10.1007/s12281-010-0034-6 Zain, 2012, Predictors of cure, amputation and follow-up dropout among patients with mycetoma seen at the Mycetoma Research Centre, University of Khartoum, Sudan, Trans R Soc Trop Med Hyg, 106, 639, 10.1016/j.trstmh.2012.07.003 Zijlstra, 2016, Mycetoma: a unique neglected tropical disease, Lancet Infect Dis, 16, 100, 10.1016/S1473-3099(15)00359-X